LANSING, Mich., April 30, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), a worldwide leader in innovative solutions that help the food and beverage industries ensure safety and quality in ...
Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...
LANSING, Mich., Jan. 16, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay ...
LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the launch of Molecular Detection Assay - Listeria Right Now™, a rapid, enrichment-free solution for detecting ...
Comparison of machine learning algorithms for the radiomic classification of gastric subepithelial tumors. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not ...
Understanding molecular diversity is fundamental to biomedical research and diagnostics, but existing analytical tools ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
Cancer diagnoses traditionally require invasive or labor-intensive procedures such as tissue biopsies. Researchers at the Ludwig-Maximilians-Universität München (LMU) have now reported on a method ...
A bottleneck to enabling widespread access to molecular diagnostics, especially in low- and middle-income countries, has been the high cost and complex logistics associated with rapid point-of-care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback